So far, 36 cases of the eye disorder associated with GLP-1 drugs have been reported on the national database of adverse events, the TGA said
And, in some cases, even be life threatening
Essentially, the clinic administering the peptide (which the patients paid for out-of-pocket) later phoned patients to ask if they felt better, and wrote up the responses
For example, if you started a GLP-1 in September 2024 with a BMI of 37 but in July 2026 youve lost weight and now have a BMI of 34, the prescriber should attest in the prior authorization request that you met the BMI criteria of 35 or over when the GLP-1 therapy started
In these cases, inhibiting this natural enzyme could help to slow muscle breakdown, maintain strength, and stave off morbidity
Some plans may approve a trial period of three to six months with specific weight loss targets